About
Uri Galili is a biomedical scientist known for research on the anti-Gal immune response, cancer immunotherapy, vaccines, and tissue-healing applications. Public sources tie him to the University of Massachusetts Medical School as a professor/researcher and to Meridius Bio as Chief Scientific Officer. His work was also licensed into Agalimmune's Alphaject cancer-immunotherapy program, indicating influence through science and translational research rather than capital deployment.
Areas of interest
biotechimmunologycancer immunotherapyvaccine developmenttransplantationxenotransplantationregenerative medicinewound healing